检索结果 - Roger Pool

Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II) 由 Kaan Kavaklı, Renchi Yang, L. Rusen, H. Beckmann, D. Tseneklidou‐Stoeter, Monika Maas Enriquez, Renchi Yang, Yongqiang Zhao, Jing Sun, Xuefeng Wang, Depei Wu, Antonín Hluší, Katsuyuki Fukutake, Hideji Hanabusa, Teruhisa Fujii, Oscar Pérez Ramírez, Blanca Salazar Alvarado, M. Şerban, L. Rusen, Valentina Uscătescu, Cristina I. Truica, Gordana Kostić, Nada Konstantinidis, Zoran Igrutinović, F. G. Perina, T. A. Andreeva, Kaan Kavaklı, Bülent Antmen, İlgen Şaşmaz, Alphan Küpesiz, M. Akif Yeşilipek, Ching‐Tien Peng, James French, Miguel A. Escobar, Johnny Mahlangu, Roger Pool